Ameriprise Financial »

Monopar Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $374k 6.8k 54.79

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
Lam Research (LRCX)
iShares S&P 500 Index (IVV)
Chevron Corporation (CVX)
Alphabet Inc Class C cs (GOOG)
Wal-Mart Stores (WMT)
Johnson & Johnson (JNJ)
Visa (V)

View all positions for Ameriprise Financial

Top funds holding Monopar Therapeutics

Henderson Group
RA Capital Management
Adage Capital Partners GP
Saturn V Capital Management
Deerfield Management Company
BlackRock
Vanguard Group
ADAR1 Capital Management
Wellington Management Company
Vanguard Capital Management
Siren
Balyasny Asset Management
TCG Crossover Management
Polar Capital Holdings
Alyeska Investment Group

View all funds holding Monopar Therapeutics